← Back to Search

Text Message Reminders for Heart Attack (BURST Trial)

N/A
Waitlist Available
Led By Avinash Pandey
Research Sponsored by Cambridge Cardiac Care Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 1-12
Awards & highlights

BURST Trial Summary

This is a 2x2 study examining the impacts of a novel exercise regimen and daily text message reminders in patients at high risk for cardiovascular disease. Patients participating in cardiac rehabilitation will be randomized to either moderate intensity continuous training (MICT) or a novel exercise regimen consisting of three periods of high intensity exercise, called BURST exercise. Additionally, half of the patients in each exercise group will be randomized to receive daily text message reminders to improve adherence to the prescribed exercise regimen.

Eligible Conditions
  • Heart Attack
  • Coronary Artery Disease
  • Congestive Heart Failure
  • Atrial Fibrillation
  • Type 2 Diabetes

BURST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 1-12
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 1-12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HbA1C at 12 months
Secondary outcome measures
BMI at 12 months
BMI at 3 months
Exercise Capacity at 12 months
+9 more

BURST Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Text Message RemindersExperimental Treatment2 Interventions
Patients in the "Text Message Reminders" arm of the study performed Moderate Intensity Continuous Training and received text message reminders.
Group II: BURST and Text Message RemindersExperimental Treatment2 Interventions
Patients in the "BURST and Text Message Reminders" arm of the study performed Burst physical activity and received text message reminders
Group III: BURSTExperimental Treatment1 Intervention
Patients in the "BURST" arm of the study performed BURST physical activity and did not receive text message reminders
Group IV: ControlActive Control1 Intervention
Patients in the "Control" arm of the study performed Moderate Intensity Continuous Training (MICT) and did not receive text message reminders.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Moderate Intensity Continuous Training
2020
N/A
~40
Text Message Reminders
2010
N/A
~160

Find a Location

Who is running the clinical trial?

Cambridge Cardiac Care CentreLead Sponsor
2 Previous Clinical Trials
595 Total Patients Enrolled
Avinash PandeyPrincipal InvestigatorWestern University, Canada

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
New England Journal of MedicineJournal
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
“Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin”. 2002. “Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin”. New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmoa012512.
clinicaltrials.govStudy
Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease
2014. "Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03103854.
All > Osteopenia > Cardiovascular
~44 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top